BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 25727255)

  • 1. Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery.
    Fang Y
    Expert Opin Drug Discov; 2015 Apr; 10(4):331-43. PubMed ID: 25727255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troubleshooting and deconvoluting label-free cell phenotypic assays in drug discovery.
    Fang Y
    J Pharmacol Toxicol Methods; 2013; 67(2):69-81. PubMed ID: 23340025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular topology as a novel approach for drug discovery.
    Gálvez J; Gálvez-Llompart M; García-Domenech R
    Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Label-free cell phenotypic drug discovery.
    Fang Y
    Comb Chem High Throughput Screen; 2014; 17(7):566-78. PubMed ID: 24517833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico drug discovery approaches on grid computing infrastructures.
    Wolf A; Shahid M; Kasam V; Ziegler W; Hofmann-Apitius M
    Curr Clin Pharmacol; 2010 Feb; 5(1):37-46. PubMed ID: 19642967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of machine learning approaches for novel drug discovery.
    Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
    Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational polypharmacology: a new paradigm for drug discovery.
    Chaudhari R; Tan Z; Huang B; Zhang S
    Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-aided drug discovery and development.
    Zhang S
    Methods Mol Biol; 2011; 716():23-38. PubMed ID: 21318898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential strategies for increasing drug-discovery productivity.
    Cumming JG; Finlay MR; Giordanetto F; Hemmerling M; Lister T; Sanganee H; Waring MJ
    Future Med Chem; 2014 Apr; 6(5):515-27. PubMed ID: 24649955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
    Thomas CE; Will Y
    Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How far can virtual screening take us in drug discovery?
    Kar S; Roy K
    Expert Opin Drug Discov; 2013 Mar; 8(3):245-61. PubMed ID: 23330660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-receptor interaction platforms and their applications for drug discovery.
    Fang Y
    Expert Opin Drug Discov; 2012 Oct; 7(10):969-88. PubMed ID: 22860803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment-based lead discovery on G-protein-coupled receptors.
    Visegrády A; Keserű GM
    Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound annotation with real time cellular activity profiles to improve drug discovery.
    Fang Y
    Expert Opin Drug Discov; 2016; 11(3):269-80. PubMed ID: 26787137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and challenges in phenotypic drug discovery: an industry perspective.
    Moffat JG; Vincent F; Lee JA; Eder J; Prunotto M
    Nat Rev Drug Discov; 2017 Aug; 16(8):531-543. PubMed ID: 28685762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
    Betz UA
    Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To measure is to know: an approach to CADD performance metrics.
    Loughney D; Claus BL; Johnson SR
    Drug Discov Today; 2011 Jul; 16(13-14):548-54. PubMed ID: 21605697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational chemistry at Janssen.
    van Vlijmen H; Desjarlais RL; Mirzadegan T
    J Comput Aided Mol Des; 2017 Mar; 31(3):267-273. PubMed ID: 27995515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.